Suppr超能文献

老年患者动静脉内瘘的建立:最佳时机是什么时候?

Arteriovenous fistula placement in the elderly: when is the optimal time?

作者信息

Hod Tammy, Patibandla Bhanu K, Vin Yael, Brown Robert S, Goldfarb-Rumyantzev Alexander S

机构信息

Division of Nephrology, Center for Vascular Biology Research, Department of Medicine, and

Department of Medicine, St. Vincent Hospital, University of Massachusetts School of Medicine, Worcester, Massachusetts; and.

出版信息

J Am Soc Nephrol. 2015 Feb;26(2):448-56. doi: 10.1681/ASN.2013070740. Epub 2014 Aug 28.

Abstract

Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD). However, many AVFs fail before starting dialysis. To assess the optimal time for AVF placement in the elderly, we linked data from the US Renal Data System with Medicare claims data to identify 17,511 patients ≥67 years old on incident HD who started dialysis between January 1, 2005, and December 31, 2008, with an AVF placed as the first predialysis access. AVF success was defined as dialysis initiation using the AVF, with time between AVF placement and dialysis start as our primary variable of interest. The mean age was 76.1±6.0 years, and 58.3% of subjects were men. Overall, 54.9% of subjects initiated dialysis using an AVF, and 45.1% of subjects used a catheter or graft. The success rate increased as time from AVF creation to HD initiation increased from 1-3 months (odds ratio [OR], 0.49; 95% confidence interval [95% CI], 0.44 to 0.53) to 3-6 months (OR, 0.93; 95% CI, 0.85 to 1.02) to 6-9 months (OR, 0.99; 95% CI, 0.88 to 1.11) but stabilized after that time. Furthermore, the number of interventional access procedures increased over time starting at 1-3 months, with a mean of 0.64 procedures/patient for AVFs created 6-9 months predialysis compared with 0.72 for AVFs created >12 months predialysis (P<0.001). Although limited by the observational nature of this study, our results suggest that placing an AVF >6-9 months predialysis in the elderly may not associate with a better AVF success rate.

摘要

动静脉内瘘(AVF)是血液透析(HD)首选的血管通路。然而,许多动静脉内瘘在开始透析前就失败了。为了评估老年患者动静脉内瘘置入的最佳时机,我们将美国肾脏数据系统的数据与医疗保险理赔数据相链接,以识别出2005年1月1日至2008年12月31日期间开始透析的17511例年龄≥67岁的新发血液透析患者,这些患者首次透析前的血管通路为动静脉内瘘。动静脉内瘘成功的定义为使用该动静脉内瘘开始透析,动静脉内瘘置入与透析开始之间的时间作为我们主要关注的变量。平均年龄为76.1±6.0岁,58.3%的受试者为男性。总体而言,54.9%的受试者使用动静脉内瘘开始透析,45.1%的受试者使用导管或移植血管。随着从动静脉内瘘建立到开始血液透析的时间从1 - 3个月(优势比[OR],0.49;95%置信区间[95%CI],0.44至0.53)增加到3 - 6个月(OR,0.93;95%CI,0.85至1.02)再增加到6 - 9个月(OR,0.99;95%CI,0.88至1.11),成功率有所上升,但此后趋于稳定。此外,从1 - 3个月开始,介入性血管通路手术的数量随时间增加,透析前6 - 9个月建立的动静脉内瘘患者平均每人有0.64次手术,而透析前>12个月建立的动静脉内瘘患者平均每人有0.72次手术(P<0.001)。尽管本研究受观察性研究性质的限制,但我们的结果表明,在老年患者透析前>6 - 9个月置入动静脉内瘘可能与更好的动静脉内瘘成功率无关。

相似文献

4
Outcomes of Elderly Patients after Predialysis Vascular Access Creation.透析前血管通路建立后老年患者的结局
J Am Soc Nephrol. 2015 Dec;26(12):3133-40. doi: 10.1681/ASN.2014090938. Epub 2015 Apr 8.

引用本文的文献

9
The arteriovenous access stage (AVAS) classification.动静脉通路阶段(AVAS)分类
Clin Kidney J. 2020 Nov 20;14(7):1747-1751. doi: 10.1093/ckj/sfaa189. eCollection 2021 Jul.

本文引用的文献

2
Fistula first is not always the best strategy for the elderly.对于老年人来说,瘘管先行并不总是最佳策略。
J Am Soc Nephrol. 2013 Jul;24(8):1297-304. doi: 10.1681/ASN.2012060632. Epub 2013 Jun 27.
3
Vascular access in haemodialysis: strengthening the Achilles' heel.血液透析中的血管通路:加强薄弱环节。
Nat Rev Nephrol. 2013 Jun;9(6):348-57. doi: 10.1038/nrneph.2013.76. Epub 2013 Apr 16.
4
Thrombophilia and arteriovenous fistula survival in ESRD.血栓形成倾向与终末期肾病患者动静脉瘘的生存
Clin J Am Soc Nephrol. 2013 Jun;8(6):962-8. doi: 10.2215/CJN.03860412. Epub 2013 Feb 14.
6
Challenges and management of high-flow arteriovenous fistulae.高流量动静脉瘘的挑战与管理。
Semin Nephrol. 2012 Nov;32(6):545-50. doi: 10.1016/j.semnephrol.2012.10.005.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验